Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
NAV17/05/2024 | Chg.-1.4800 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
198.8700CHF | -0.74% | reinvestment | Equity Worldwide | Candriam ▶ |
GlobeNewswire
15:50
Kingsview Wealth Management Expands Servicing Relationship with Ultimus to Assist in Launch of Four ...
GlobeNewswire
12:55
YieldMax™ Launches Option Income Strategy ETF on the VanEck® Gold Miners ETF (GDX®)
GlobeNewswire
20/05
Kayne Anderson Energy Infrastructure Fund Completes Private Placement of $75 Million of Notes